Dionex to purchase ESA Biosciences’ HPLC portfolio
Dionex has entered into an asset purchase agreement with ESA Biosciences, a wholly owned subsidiary of Magellan Biosciences, to purchase ESA Biosciences’ HPLC-related products, HPLC clinical assays, laboratory services and assets.
This acquisition will add three HPLC detector families to the Dionex HPLC product portfolio:
- Corona Family of Universal Charged Aerosol Detectors (CAD) is the ‘universal’ HPLC detector targeting pharmaceutical and biopharmaceutical development, manufacturing and QA/QC processes.
- CoulArray and Coulochem detectors are electrochemical detectors targeting neuroscience, clinical, and metabolomics research applications.
Combined with Dionex expertise in electrochemistry detection for carbohydrates and glycobiology, this acquisition will position Dionex as the leading provider of comprehensive electrochemistry solutions for liquid chromatography.
ATSE names Jane O'Dwyer as its new CEO
O'Dwyer is an executive leader with more than 30 years' experience across higher...
Director of scientific R&D firm fined $195K+ over biogas experiments
The fine follows a 2022 incident in which a doctor sustained serious injuries after exposure to...
7th edition of STEM Equity Monitor now available
The latest national data resource on diversity in STEM has new design features intended to...
